Cefic condemns trade union Reach authorisation list

31 March 2009 15:01  [Source: ICIS news]

PARIS (ICIS News)--The European Trade Union Confederation (ETUC) presented a list of priority chemicals for authorisation under Reach to the European Parliament on Tuesday, but the initiative was strongly condemned by Cefic, the European Chemical Industry Council.

The ETUC, backed by Italian member of the European Parliament (MEP) Guido Sacconi, said the 306 substances of very high concern that appeared on its list, “especially the 191 that cause recognised occupational diseases”, should be included on the candidate list of substances for authorisation under Reach. 

They said this was necessary to reduce the number of occupational diseases in the EU due to the exposure of hazardous chemicals.

“The future of Europe’s chemicals industry depends on it producing and marketing chemicals that are safer for human and environmental health,” said Joel Decaillon, the ETUC’s confederal secretary.

Cefic said it “regretted the publication of such a list, which has no legal value and is not part of the Reach process”.

“It includes a whole range of high volume substances, which are only used as intermediates and therefore do not even fall under authorisation,” added the organisation.

Cefic reminded the ETUC that “the Reach process is governed by the European Chemicals Agency (ECHA), which is the sole body responsible for publishing the candidate list of substances that…might end up on the official candidate list of substances eligible to come under the authorisation element of Reach”.

ECHA published a first list of substances in June 2008, which will be added to with substances proposed by EU member states.

To discuss issues facing the chemical industry go to ICIS connect


By: Philippa Jones
+44 20 8652 3214



AddThis Social Bookmark Button

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly